Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

40.020
-1.320-3.19%
Volume:22.33M
Turnover:892.98M
Market Cap:165.60B
PE:45.05
High:41.000
Open:41.000
Low:39.440
Close:41.340
52wk High:44.000
52wk Low:16.200
Shares:4.14B
HK Float Shares:4.14B
Volume Ratio:1.44
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.888
ROE:10.50%
ROA:5.89%
PB:3.25
PE(LYR):45.05
PS:7.29

Loading ...

Vertex posts FY2025 GAAP operating income of USD 4.17 billion

Reuters
·
6 hours ago

Morgan Stanley Forecasts WuXi Biologics Shares to Rise in Next 45 Days, Raises Target Price to HK$50

Stock News
·
Yesterday

WUXI BIO Shares Surge Over 6% Again on Stronger-Than-Expected Second-Half Profit and Margin Expansion

Stock News
·
Yesterday

Wuxi Biologics (Cayman) Stock Rallies 3.4% in Hong Kong

Dow Jones
·
Feb 11

China stocks steady as metals rally counters consumer, AI losses

Reuters
·
Feb 11

BUZZ-WuXi Biologics climbs to 4-month high on robust earnings estimates

Reuters
·
Feb 11

BRIEF-Wuxi Biologics FY Revenue RMB21,790 Million

Reuters
·
Feb 11

WUXI BIO Issues Positive Profit Alert, Anticipates 46.3% Rise in Annual Shareholder Profit

Stock News
·
Feb 11

WuXi Biologics (Cayman) Inc. (Stock Code: 2269) Anticipates Notable Profits Growth for FY2025

Bulletin Express
·
Feb 11

WuXi Biologics (Cayman) Inc. (2269) Schedules Board Meeting to Review 2025 Annual Results

Bulletin Express
·
Feb 11

WuXi Biologics Board to Approve Annual Results

Reuters
·
Feb 11

Wuxi Biologics Expects 2025 Revenue to Rise 16.7% to RMB21.79 Billion

Reuters
·
Feb 11

WuXi Biologics -FY Profit Expected to Increase to RMB5,733 Mln

THOMSON REUTERS
·
Feb 11

Biopharmaceutical Stocks Show Broad Gains with CSPC PHARMA Leading with Over 7% Rise

Deep News
·
Feb 10

CRO Stocks Lead Gains as Biopharma Investment and Cross-Border Deals Rebound

Stock News
·
Feb 10

Wuxi Biologics (Cayman) Stock Rises 1.5% in Hong Kong

Dow Jones
·
Feb 09

WuXi Biologics Receives EcoVadis Platinum Medal for Third Consecutive Year

Reuters
·
Feb 09

WuXi Biologics Alliances Deepen Role In Complex Autoimmune And Fusion Drugs

Simply Wall St.
·
Feb 06

Wuxi Biologics (Cayman) Stock Advances 2.6% in Hong Kong

Dow Jones
·
Feb 05

Wuxi XDC Cayman Inc. verschiebt Versand der Angebotsunterlagen

Reuters
·
Feb 04